S. N. Fontain

Feasibility of Identifying Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease.

M. Hughes, S. Swindells, U. Lalloo, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV testing uptake among the household contacts of multidrug-resistant tuberculosis index cases in eight countries.

M. Hughes, S. Swindells, R. Dawson, 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Cost-Effectiveness of Rapid Syphilis Screening in Prenatal HIV Testing Programs in Haiti

B. Schackman, J. Pape, D. Fitzgerald, 2007, PLoS medicine.

Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial

R. Schooley, R. Gross, J. Mellors, 2022, Journal of the International AIDS Society.